1 |
Bates, J.H. and Maksym, G.N. (2011) Mechanical determinants of airways hyperresponsiveness. Crit. Rev. Biomed. Eng., 39, 281-296.
DOI
|
2 |
Cockcroft, D.W. (2010) Direct challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest, 138, 18S-24S.
DOI
ScienceOn
|
3 |
Nakagome, K. and Nagata, M. (2011) Pathogenesis of airway inflammation in bronchial asthma. Auris Nasus Larynx, 38, 555-563.
DOI
ScienceOn
|
4 |
Brightling, C.E. (2011) Eosinophils, bronchitis and asthma; Pathogenesis of cough and air flow obstruction. Pulm. Pharmacol. Ther., 24, 324-327.
DOI
ScienceOn
|
5 |
Amin, K. (2012) The role of mast cells in allergic inflammation. Respir. Med., 106, 9-14.
DOI
ScienceOn
|
6 |
Bosnjak, B., Stelzmueller, B., Erb, K.J. and Epstein, M.M. (2011) Treatment of allergic asthma: Modulation of Th2 cells and their responses. Respir. Res., 12, 114.
DOI
|
7 |
Bullen, C., McRobbie, H., Thornley, S., Glover, M., Lin, R. and Laugesen, M. (2010) Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob. Control, 19, 98-103.
DOI
ScienceOn
|
8 |
Kim, D.S., Kim, S.H., Kim, B.K., Yang, M.C. and Ma, J.Y. (2012) Antiasthmatic effects of herbal complex MA and its fermented product MA128. Evid. Based Complement. Altern. Med., 2012, 769508.
|
9 |
Kim, S.H., Kim, B.K. and Lee, Y.C. (2011) Antiasthmatic effects of hesperidin, a potential Th2 cytokine antagonist, in a mouse model of allergic asthma. Mediators Inflammation, 2011, 485402.
|
10 |
Cieslewicz, G., Tomkinson, A., Adler, A., Duez, C., Schwarze, J., Takeda, K., Larson, K.A., Lee, J.J., Irvin, C.G. and Gelfand, E.W. (1999) The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J. Clin. Invest., 104, 301-308.
DOI
ScienceOn
|
11 |
Lee, Y.C., Kim, S.H., Seo, Y.B., Roh, S.S. and Lee, J.C. (2006) Inhibitory effects of Actinidia polygama extract and cyclosporine A on OVA-induced eosinophilia and bronchial hyperresponsiveness in a murine model of asthma. Int. Immunopharmacol., 6, 703-713.
DOI
ScienceOn
|
12 |
Barnes, P.J. (2011) Pathophysiology of allergic inflammation. Immunol. Rev., 242, 31-50.
DOI
ScienceOn
|
13 |
Barlow, R.B. and McLeod, L.J. (1969) Some studies on cytosine and its methylated derivatives. Br. J. Pharmacol., 35, 161-174.
DOI
|
14 |
Food and Drug Administration. (2010) Summary of Results: Laboratory Analysis of Electronic Cigarettes Conducted By FDA, FDA, US, pp. 1.
|
15 |
Etter, J.F. (2010) Electronic cigarettes: a survey of users. BMC Public Health, 10, 231.
DOI
ScienceOn
|
16 |
Etter, J.F. and Bullen, C. (2011) Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction, 106, 2017-2028.
DOI
ScienceOn
|
17 |
Caponnetto, P., Auditore, R., Russo, C., Cappello, G.C. and Polosa, R. (2013) Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: A prospective 12-month pilot study. Int. J. Environ. Res. Public Health, 10, 446-461.
DOI
|
18 |
Flouris, A.D., Chorti, M.S., Poulianiti, K.P., Jamurtas, A.Z., Kostikas, K., Tzatzarakis, M.N., Wallace Hayes, A., Tsatsakis, A.M. and Koutedakis, T. (2013) Acute impact of active and passive electronic cigarette smoking on serum cotinin and lung function. Inhalation Toxicol., 25, 91-101.
DOI
ScienceOn
|
19 |
Siegel, M.B., Tanwar, K.L. and Wood, K.S. (2011) Electronic cigarettes as a smoking-cessation tool. Results from an online survey. Am. J. Prev. Med., 40, 472-475.
DOI
ScienceOn
|
20 |
Vansickel, A.R., Cobb, C.O., Weaver, M.F. and Eissenberg, T.E. (2010) A clinical laboratory model for evaluating the acute effects of electronic ''cigarettes'': nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol. Biomarkers Prev., 19, 1945-1953.
DOI
ScienceOn
|
21 |
Lee, S., Kimm, H., Yun, J.E. and Jee, S.H. (2011) Public health challenges of electric cigarettes in South Korea. J. Prev. Med. Public Health, 44, 235-241.
DOI
ScienceOn
|
22 |
Laugesen, M. (2008) Safety report on the Ruyan e-cigarette cartridge and inhaled aerosol, Health New Zealand Ltd, New Zealand, pp. 1-23.
|
23 |
Uryupin, A.B., Peregudov, A.S., Kochetkov, K.A., Bulatnikova, L.N., Kiselev, S.S. and Nekrasov, Y.S. (2013) Qualitative and quantitative compositions of fluids for electronic cigarettes. Pharm. Chem. J., 46, 687-692.
DOI
|
24 |
Polosa, R., Caponnetto, P., Morjaria, J.B., Papale, G., Campagna, D. and Russo, C. (2011) Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health, 11, 786.
DOI
|
25 |
Ingebrathsen, B.J., Cole, S.K. and Alderman, S.L. (2012) Electronic cigarette aerosol particle size distribution measurements. Inhalation Toxicol., 24, 976-984.
DOI
ScienceOn
|
26 |
Kuschner, W.G., Reddy, S., Mehrotra, N. and Paintal, H.S. (2011) Electronic cigarettes and thirdhand tobacco smoke: two emerging health care challenges for the primary care provider. Int. J. Gen. Med., 4, 115-120.
|
27 |
Tomkinson, A., Duez, C., Cieslewicz, G., Pratt, J.C., Joetham, A., Shanafelt, M.C., Gundel, R. and Gelfand, E.W. (2001) A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J. Immunol., 166, 5792-5800.
DOI
|